JB/CALL/DOCMORRIS/90/0.05/21.06.24 Stock

JB/CALL/DOCMORRIS/90/0.05/21.06.24 Share Price

DOZUJB

CH1321760865

Market Closed - Swiss Exchange 08:50:01 08/05/2024 pm IST
0.11 ^CHF	-52.17%

Current month	-57.69%
1 month	-82.26%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart DOCMORRIS AG

Chart JB/CALL/DOCMORRIS/90/0.05/21.06.24

Latest news about DOCMORRIS AG

DocMorris AG: Daniel Wüest becomes new CFO at DocMorris	10:33am	EQ
DocMorris announces the start of the tender offer period for its Outstanding Convertible Bonds due 2025	06/05	EQ
Resolutions of the 31st Annual General Meeting of DocMorris AG of 2 May 2024 in Zurich	02/05	EQ
Final allocation of DocMorris CHF 200 million Convertible Bonds Offering	30/04	EQ

More news

Quotes 5-day view

Date	Price	Change
08/24/08	0.11	-52.17%
07/24/07	0.23	-11.54%
06/24/06	0.26	+8.33%
03/24/03	0.24	+4.35%
02/24/02	0.23	-11.54%

Delayed Quote Swiss Exchange

Last update May 08, 2024 at 08:50 pm IST

More quotes

Static data

Product type	Plain-Vanilla-Warrants
Buy / Sell	CALL
Underlying	DOCMORRIS AG
Issuer	Bank Julius Bär
	DOZUJB
ISIN	CH1321760865
Date issued	07/02/2024
Strike	90 CHF
Maturity	21/06/2024 (44 Days)
Parity	20 : 1
Emission price	0.65 CHF
Emission volume	N/A
Settlement	both
Currency	CHF

Technical Indicators

Highest since issue	0.98 CHF
Lowest since issue	0.11 CHF
Spread	0.01 CHF
Spread %	9.09%

Company Profile

Zur Rose Group AG is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. The Company's activities are divided into two business segments: Zur Rose and DocMorris. The Zur Rose division includes wholesale business and provides drugs to medical doctors, health insurance companies, hospitals and healthcare companies, among others. The DocMorris division manages the mail-order business for drug retail. The Company operates in Switzerland, Germany and the Netherlands through a number of subsidiaries, such as Zur Rose Suisse AG, Zur Rose Pharma GmbH, BlueCare AG, DocMorris NV, Eurapon Pharmahandel GmbH and Vitalsana BV.

Sector

More about the company

Ratings for DocMorris AG

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Consensus: DocMorris AG

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

75 CHF

Average target price

99.24 CHF

Spread / Average Target

+32.32%

Consensus